Development and clinical application of an evidence-based pharmaceutical care service algorithm in acute coronary syndrome

2018 ◽  
Vol 43 (3) ◽  
pp. 366-376 ◽  
Author(s):  
J. E. Kang ◽  
J. M. Yu ◽  
J. H. Choi ◽  
I.-M. Chung ◽  
W. B. Pyun ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Pharmaceutical Care ◽  
Clinical Application ◽  
Care Service ◽  
Evidence Based ◽  
Coronary Syndrome ◽  
Pharmaceutical Care Service

scholarly journals Economic evaluation of outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service

2011 ◽  
Vol 55 (9) ◽  
pp. 686-691 ◽  
Author(s):  
Anna Paula de Sá Borges ◽  
Camilo Molino Guidoni ◽  
Osvaldo de Freitas ◽  
Leonardo Régis Leira Pereira
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Pharmaceutical Care ◽  
Care Service ◽  
Emergency Department Visits ◽  
Care Group ◽  
Control Group ◽  
Pharmaceutical Care Service

OBJECTIVE: To analyze the costs related to visits and drug prescription in outpatients with type 2 diabetes mellitus assisted by a pharmaceutical care service. SUBJECTS AND METHODS: A prospective and experimental study was carried out. Seventy one patients were divided into two groups: control and pharmaceutical care. Patients in the pharmaceutical care group were followed up monthly by a single clinical pharmacist. RESULTS: The pharmaceutical care group had a statistically significant reduction in costs of metformin and emergency department visits, and increased costs with their family physicians. On the other hand, the control group had a statistically significant increase of 21.3% in the general costs of treatment and visits. CONCLUSION: The pharmaceutical care group maintained the same costs related to drugs and visits, while the control group showed a significant increase in general costs.

scholarly journals CV2 Age, Dementia, and Evidence-Based Medication Use After Admission for Acute Coronary Syndrome

2012 ◽  
Vol 15 (7) ◽  
pp. A607
Author(s):  
C.F. Lin ◽  
F.Y. Hsiao ◽  
F.L.L. Wu ◽  
C.H. Bai ◽  
C.S. Gau ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Medication Use ◽  
Evidence Based ◽  
Coronary Syndrome

Medication Regimen Complexity Index

2020 ◽  
Vol 35 (2) ◽  
pp. 50-51
Author(s):  
Wei Terk Chang
Keyword(s):  
Clinical Practice ◽  
Pharmaceutical Care ◽  
Care Service ◽  
Medication Therapy Management ◽  
Medication Regimen ◽  
Medication Therapy ◽  
Medication Regimen Complexity ◽  
Complexity Index ◽  
Regimen Complexity ◽  
Pharmaceutical Care Service

This complexity index could be used in clinical practice to more accurately target patients who would benefit from intensive pharmaceutical care service such as medication therapy management.

Utilization of Evidence-Based Therapy for Acute Coronary Syndrome in High Income and Middle/Low Income Countries

2013 ◽  
Vol 29 (10) ◽  
pp. S297-S298
Author(s):  
A. Shimony ◽  
S.M. Grandi ◽  
L. Pilote ◽  
L. Joseph ◽  
J. O'Loughlin ◽  
...  
Keyword(s):  
Acute Coronary Syndrome ◽  
Low Income ◽  
High Income ◽  
Low Income Countries ◽  
Evidence Based ◽  
Coronary Syndrome ◽  
Evidence Based Therapy
Sign in / Sign up

Export Citation Format

Share Document